Zenyte, Made in USA launch public-market infrastructure for independent healthcare

Zenyte Holdings and Made in USA Inc. said they are building a repeatable framework to connect independent healthcare practices with institutional capital while preserving physician control. The companies also plan to explore trusted-data tools, including verification and permissioned data systems, across future healthcare portfolios.

Why it matters: - The relationship is designed to give independent doctors access to institutional scale and capital-market pathways without forcing them to surrender clinical or operational control. - The model aims to create repeatable healthcare portfolios built from real operating practices, which could expand options for investors, strategic partners and future data applications. - The companies say the framework could support trusted healthcare data infrastructure, including more secure handling, verification and permissioning of patient data over time.

What happened: - Zenyte Holdings Corp. and Made in USA Inc. (OTC: USDW) announced a strategic relationship on August 25, 2026. - The announcement was made in Boca Raton, Florida. - Zenyte described the relationship as a new public-market pathway for independent healthcare practices. - USDW is intended to provide a public-market pathway and a platform for complementary technologies and portfolio-level initiatives.

The details: - Zenyte says its framework combines technology, financial organization, audit preparation, transaction infrastructure and portfolio construction. - The model is built to help independent practices prepare for institutional participation while preserving physician leadership. - Zenyte has verified more than $100 million in practice collections from supporting financial records. - Zenyte also says it is building relationships with a broader network of independent practices that could support multiple healthcare portfolios over time. - The company describes the approach as “Portfolio Manufacturing™,” a repeatable system for organizing qualifying independent businesses into purpose-built portfolios. - Each portfolio can be structured around different market opportunities, specialties, strategic objectives and long-term partnerships. - Zenyte says the infrastructure can then be reused for the next portfolio. - The company says portfolios may support strategic ventures, long-term financial partnerships, technology deployment, acquisitions, ancillary services and other investments. - Zenyte said doctors would continue doing the clinical work they already do while long-term partners participate in value created by the portfolio structure. - Made in USA Inc. says its infrastructure includes data provenance, verification, certification and permissioned data systems. - USDW’s disclosed technologies include DataWallet™ technology, ERP and IoT capabilities, and blockchain-based verification infrastructure. - USDW has also publicly announced a proposed venture in the life sciences business segment focused on secure, verifiable and permissioned data ecosystems. - Zenyte expects to evaluate how trusted-data infrastructure could support participating practices, clinical and research applications, responsible AI and future patient data transparency. - Austin Reiser of Zenyte Holdings said the missing piece is the infrastructure connecting independent physicians, long-term capital and future healthcare technologies without compromising physician independence.

Between the lines: - The announcement signals an effort to build infrastructure, not just complete a one-off deal. - The emphasis on repeatability suggests Zenyte wants a platform that can be used across multiple healthcare transactions and specialties. - The data component points to a broader strategy: pairing healthcare operations with verified data systems that could later support research, AI and patient-facing permissions. - The structure also positions physician independence as a selling point, not a tradeoff.

What's next: - Zenyte and USDW said contemplated transactions remain subject to diligence, negotiation and definitive agreements. - Any future deals would also depend on audits, financing, regulatory approvals, securities-law compliance and other closing conditions where applicable. - The companies expect to keep evaluating portfolio formations, healthcare-data initiatives, strategic ventures and other partnership opportunities. - Future work could include building additional portfolios and testing how trusted-data tools fit within the healthcare ecosystem.

The bottom line: - Zenyte and Made in USA are pitching a repeatable public-market structure for independent healthcare practices, with capital, scale and data infrastructure built around physician control.